Preclinical efficacy and safety evaluation of BD211 autologous CD34+ hematopoietic stem cell injection for transfusion-dependent β-thalassemia in NCG-X mice
Xuedong Dai, Zike Li, Shuang Chen, Ying Huang, Sikai Ling, Quanjun Wang, Qi Wang
TL;DR
This study evaluates the safety and effectiveness of a stem cell treatment for β-thalassemia in mice, finding it safe and capable of producing human red blood cells.
Contribution
The study provides preclinical evidence of BD211's safety and efficacy in a mouse model of β-thalassemia.
Findings
BD211 engrafted and differentiated into human erythroid cells in mouse bone marrow and blood.
No adverse effects were observed in mice administered BD211.
The no observed adverse effect level was established at 1.2 × 10⁶ cells per mouse.
Abstract
Autologous CD34+ hematopoietic stem cell-based therapies have shown promise in addressing therapeutic needs. However, a comprehensive evaluation of their efficacy and safety is crucial before clinical application. This study aimed to assess the efficacy and safety profile of BD211 autologous CD34+ hematopoietic stem cell injection in NCG-X mice. NCG-X mice were administered BD211 intravenously at doses of 4.0 × 105 and 1.2 × 106 cells per mouse, followed by withdrawal and observation for 13 weeks. Efficacy was evaluated by monitoring the engraftment and differentiation of BD211 into human erythroid cells within the mouse bone marrow and blood. Safety was assessed through clinical observation, pathology, organ weight measurements, and histopathology. Toxicokinetic studies and distribution of BD211 were determined via validated quantitative PCR. Mortality was observed in all groups of…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHemoglobinopathies and Related Disorders · Blood groups and transfusion · Erythrocyte Function and Pathophysiology